Dr. Malgorzata B. Franczak, MD
- Medicare services, 2024
- 99
- Medicare patients, 2024
- 56
- Part D claims, 2024
- 410
- Publications
- 15
- Clinical trials
- 5
- Practice address
- 9200 W Wisconsin Ave, Milwaukee, WI 53226
- Practice phone
- Call (414) 805-3000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Franczak's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Malgorzata B. Franczak is a neurologist in Milwaukee, Wisconsin
Dr. Franczak practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.
Dr. Franczak's NPI, 1558312488, was assigned on May 15, 2006. Dr. Franczak holds Wisconsin license 37471.
- NPI
- 1558312488NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3577648088
- NPI enumeration date
- May 15, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (414) 805-3000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 64
- Medical school graduation
- 1988
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Malgorzata B. Franczak practices at Froedtert Hospital in Milwaukee, Wisconsin
Dr. Franczak's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.
- Froedtert Hospital9200 W Wisconsin Ave, Milwaukee, WI 53226 · Milwaukee CountyPhone(414) 805-3000
Source: Dmand AI Affiliation Data
Dr. Malgorzata B. Franczak is affiliated with 1 site of care and 1 medical group
Dr. Franczak's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Malgorzata B. Franczak's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Franczak practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Froedtert Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Froedtert ThedaCare Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Malgorzata B. Franczak is one of 330 neurologists in Wisconsin
Neurology is Dr. Franczak's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Franczak is licensed in Wisconsin.
Specialties and state licenses
- Neurology, WisconsinPrimary
Neurologists near Dr. Franczak
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Malgorzata B. Franczak billed Medicare for 99 services in 2024
CMS data shows 99 Medicare services from Dr. Franczak across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $5,590 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Franczak's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 582024: 7021%
- Other services
- 2023: 02024: 29
Dr. Franczak compared with the Wisconsin median for neurologists, 2024
- Dr. Franczak
- Wisconsin median
- Medicare services
- 99vs 24960% below
- Medicare patients
- 56vs 16466% below
- Part D claims
- 355vs 55636% below
Medians across 332 neurologists in Wisconsin with Dmand AI profiles that report each measure.
Dr. Franczak's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Franczak?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Franczak and other neurologists in Wisconsin.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Malgorzata B. Franczak treated 56 Medicare patients in 2024, average age 76
CMS counts 56 Medicare patients who saw Dr. Franczak in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.01, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Franczak's median patient age at 77, with 54% women.
Dr. Franczak's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Franczak's Medicare patients by sex, 2024
- Women3155%
- Men2545%
Chronic conditions among Dr. Franczak's Medicare patients, 2024
- High cholesterol75%
- High blood pressure64%
- Alzheimer's and dementia54%
- Arthritis39%
- Diabetes23%
- Ischemic heart disease23%
- Anxiety21%
- Chronic kidney disease21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Franczak's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 77
Patient panel by sex, all payers
- Women54%
- Men44%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Malgorzata B. Franczak wrote 410 Medicare Part D claims in 2024
In 2024, Dr. Franczak wrote 410 Medicare Part D claims for 93 patients. 97% of them were for generic drugs. CMS names the drug for 355 of them, across 4 drugs with 11 or more claims each, at $7,717 in total drug cost. In 2023, CMS named 375 claims across 5 drugs.
Dr. Franczak's Part D claims by kind of drug, 2024
- Generic397 claims97%
- Brand-name13 claims3%
Dr. Franczak's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3752024: 3555%
Drugs named by CMS: 4 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Malgorzata B. Franczak scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Franczak for performance year 2024, reported as part of a group. Dr. Franczak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Franczak's MIPS scores, performance year 2024
- 88of 100Final score
- 82.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Malgorzata B. Franczak has 15 publications on record
Dmand AI links 15 papers to Dr. Franczak, published from 2010 to 2025. 2011 was the busiest year, with 3. The most frequent topics are Cognitive Dysfunction, Neuropsychological Tests and Brain. Dr. Franczak has published most often in J Int Neuropsychol Soc. Dr. Franczak's most frequent co-authors are Piero G. Antuono, MD, Jennifer Lynn Jones, MD and Joseph S. Goveas, MD.
Dr. Franczak's papers by year, 2010 to 2025
Topics Dr. Franczak writes about most
- Cognitive Dysfunction
- Neuropsychological Tests
- Brain
- Alzheimer Disease
- Hippocampus
- Magnetic Resonance Imaging
- Memory Disorders
- Amnesia
Dr. Franczak's most frequent co-authors
- Piero G. Antuono, MD7 shared papers
- Jennifer Lynn Jones, MD7 shared papers
- Joseph S. Goveas, MD6 shared papers
Recent publications by Dr. Franczak
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn
J Int Neuropsychol Soc
Ann Neurol
See who Dr. Franczak researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Franczak works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Malgorzata B. Franczak has worked on 5 clinical trials
Dmand AI links Dr. Franczak to 5 clinical trials, 2 of them phase 3 studies. Conditions studied include Alzheimer Disease and Tauopathies.
Clinical trials with Dr. Franczak by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Franczak's trials
- Alzheimer Disease
- Tauopathies
Investigators on the most trials with Dr. Franczak
- Richard F. Holub, MD3 shared trials
- Jonathan Leonard Liss, MD3 shared trials
- Marshall L. Nash, MD3 shared trials
Recent clinical trials with Dr. Franczak
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (opens in a new tab)
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects (opens in a new tab)
Network-Level Mechanisms for Preclinical Alzheimer's Disease Development (opens in a new tab)
GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Malgorzata B. Franczak received $206 in industry payments from 2023 to 2024
CMS Open Payments shows 2 general payments to Dr. Franczak from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $145.
General payments to Dr. Franczak by program year, 2023 to 2024
Companies that paid Dr. Franczak the most, 2023 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Malgorzata B. Franczak's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Malgorzata B. Franczak
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Malgorzata B. Franczak's NPI number?
Dr. Malgorzata B. Franczak's NPI number is 1558312488. It was assigned on May 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Malgorzata B. Franczak?
Dr. Malgorzata B. Franczak is a neurologist in Milwaukee, Wisconsin. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Malgorzata B. Franczak practice?
Dr. Franczak practices at 9200 W Wisconsin Ave, Milwaukee, WI 53226. Dr. Franczak's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.
What is Dr. Malgorzata B. Franczak's office phone number?
The practice phone on file for Dr. Franczak is (414) 805-3000.
What is Dr. Malgorzata B. Franczak's medical license number?
Dr. Franczak holds Wisconsin license 37471.
Which hospitals is Dr. Malgorzata B. Franczak affiliated with?
Dr. Franczak practices at Froedtert Hospital in Milwaukee, Wisconsin.
What medical group is Dr. Malgorzata B. Franczak part of?
Dr. Franczak is linked to Froedtert & the Medical College of Wisconsin Community Physicians.
Does Dr. Malgorzata B. Franczak accept Medicare?
Yes. CMS data shows Dr. Franczak billed Medicare for 99 services in 2024, and Dr. Franczak accepts Medicare assignment.
What is Dr. Malgorzata B. Franczak's MIPS score?
Dr. Franczak's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Malgorzata B. Franczak see?
CMS counts 56 Medicare patients who saw Dr. Franczak in 2024, with an average age of 76.
Show 6 more questionsShow fewer questions
What services does Dr. Malgorzata B. Franczak bill to Medicare?
In 2024, Dr. Franczak's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, new patient (99205).
What drugs does Dr. Malgorzata B. Franczak prescribe most?
In 2024 Medicare Part D data, Dr. Franczak's most prescribed drugs by claims were Donepezil HCl, Memantine HCl and Carbidopa-Levodopa.
Has Dr. Malgorzata B. Franczak received payments from drug or device companies?
CMS Open Payments shows $206 in general payments to Dr. Franczak from 2 companies from 2023 to 2024. The largest total came from Abbvie Inc.
How long has Dr. Malgorzata B. Franczak been practicing?
Dr. Franczak graduated from medical school in 1988, 38 years ago.
Does Dr. Malgorzata B. Franczak do research?
Dmand AI links 15 publications to Dr. Franczak, published from 2010 to 2025. Dr. Franczak has worked on 5 clinical trials.
Who does Dr. Malgorzata B. Franczak publish with?
Dr. Franczak's most frequent co-authors are Piero G. Antuono, MD (7 shared papers), Jennifer Lynn Jones, MD (7 shared papers) and Joseph S. Goveas, MD (6 shared papers).
Selling to neurology practices?
See neurologists in Wisconsin by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card